State Cancer Profiles

Interpretation of Incidence Rates Data

Incidence Rate Report by State

Kidney & Renal Pelvis (Late Stage^), 2018-2022

All Races (includes Hispanic), Both Sexes, All Ages

Sorted by Percentlate

Explanation of Column Headers
Incidence Rate (95% Confidence Interval) - The incidence rate is based upon 100,000 people and is an annual rate (or average annual rate) based on the time period indicated. Rates are age-adjusted by 5-year age groups to the 2000 U.S. standard million population.

Percent of Cases with Late Stage - This is the number of late stages cases compared to the number of cases for all stages.

Other Notes

• Larger confidence intervals indicate less stability of the data. This is often due to low counts that are not quite low enough to be suppressed.
• Data is currently being suppressed if there are fewer than 16 counts for the time period.

Line by Line Interpretation of the Report

US (SEER+NPCR)¹

• Rate : The incidence rate is 5.0 with a 95% confidence interval from 5.0 to 5.0 and 20,556 average annual cases over 2018-2022.
• CI*Rank ⋔ : N/A

Wyoming²

• Rate : The incidence rate is 5.2 with a 95% confidence interval from 4.5 to 6.1 and 39 average annual cases over 2018-2022.
• CI*Rank ⋔ : 21 (2, 46)
• Percent of Cases with Late Stage :

Hawaii⁷

• Rate : The incidence rate is 4.4 with a 95% confidence interval from 4.0 to 4.8 and 86 average annual cases over 2018-2022.
• CI*Rank ⋔ : 44 (26, 49)
• Percent of Cases with Late Stage :

New Mexico⁷

• Rate : The incidence rate is 5.6 with a 95% confidence interval from 5.2 to 6.0 and 152 average annual cases over 2018-2022.
• CI*Rank ⋔ : 10 (4, 27)
• Percent of Cases with Late Stage :

Rhode Island²

• Rate : The incidence rate is 5.5 with a 95% confidence interval from 5.0 to 6.1 and 80 average annual cases over 2018-2022.
• CI*Rank ⋔ : 14 (3, 35)
• Percent of Cases with Late Stage :

Vermont²

• Rate : The incidence rate is 4.8 with a 95% confidence interval from 4.2 to 5.6 and 44 average annual cases over 2018-2022.
• CI*Rank ⋔ : 30 (7, 49)
• Percent of Cases with Late Stage :

Iowa⁷

• Rate : The incidence rate is 6.4 with a 95% confidence interval from 6.0 to 6.7 and 264 average annual cases over 2018-2022.
• CI*Rank ⋔ : 3 (1, 9)
• Percent of Cases with Late Stage :

California⁷

• Rate : The incidence rate is 4.7 with a 95% confidence interval from 4.6 to 4.8 and 2,113 average annual cases over 2018-2022.
• CI*Rank ⋔ : 33 (29, 42)
• Percent of Cases with Late Stage :

Massachusetts²

• Rate : The incidence rate is 4.6 with a 95% confidence interval from 4.4 to 4.8 and 404 average annual cases over 2018-2022.
• CI*Rank ⋔ : 40 (28, 46)
• Percent of Cases with Late Stage :

Minnesota²

• Rate : The incidence rate is 5.6 with a 95% confidence interval from 5.3 to 5.9 and 398 average annual cases over 2018-2022.
• CI*Rank ⋔ : 11 (6, 23)
• Percent of Cases with Late Stage :

Washington¹

• Rate : The incidence rate is 4.8 with a 95% confidence interval from 4.6 to 5.0 and 438 average annual cases over 2018-2022.
• CI*Rank ⋔ : 32 (24, 43)
• Percent of Cases with Late Stage :

Ohio²

• Rate : The incidence rate is 5.5 with a 95% confidence interval from 5.3 to 5.7 and 833 average annual cases over 2018-2022.
• CI*Rank ⋔ : 16 (8, 23)
• Percent of Cases with Late Stage :

Indiana²

• Rate : The incidence rate is 5.8 with a 95% confidence interval from 5.5 to 6.0 and 476 average annual cases over 2018-2022.
• CI*Rank ⋔ : 7 (5, 18)
• Percent of Cases with Late Stage :

Illinois⁷

• Rate : The incidence rate is 5.4 with a 95% confidence interval from 5.3 to 5.6 and 852 average annual cases over 2018-2022.
• CI*Rank ⋔ : 18 (9, 24)
• Percent of Cases with Late Stage :

Michigan²

• Rate : The incidence rate is 4.9 with a 95% confidence interval from 4.8 to 5.1 and 651 average annual cases over 2018-2022.
• CI*Rank ⋔ : 28 (21, 35)
• Percent of Cases with Late Stage :

New Jersey⁷

• Rate : The incidence rate is 4.7 with a 95% confidence interval from 4.5 to 4.8 and 546 average annual cases over 2018-2022.
• CI*Rank ⋔ : 34 (27, 44)
• Percent of Cases with Late Stage :

West Virginia²

• Rate : The incidence rate is 6.2 with a 95% confidence interval from 5.8 to 6.7 and 159 average annual cases over 2018-2022.
• CI*Rank ⋔ : 4 (1, 13)
• Percent of Cases with Late Stage :

Kentucky⁷

• Rate : The incidence rate is 6.4 with a 95% confidence interval from 6.1 to 6.7 and 361 average annual cases over 2018-2022.
• CI*Rank ⋔ : 2 (1, 7)
• Percent of Cases with Late Stage :

Maine²

• Rate : The incidence rate is 5.1 with a 95% confidence interval from 4.7 to 5.6 and 105 average annual cases over 2018-2022.
• CI*Rank ⋔ : 24 (7, 43)
• Percent of Cases with Late Stage :

Texas⁷

• Rate : The incidence rate is 6.2 with a 95% confidence interval from 6.0 to 6.3 and 1,893 average annual cases over 2018-2022.
• CI*Rank ⋔ : 6 (2, 8)
• Percent of Cases with Late Stage :

Wisconsin²

• Rate : The incidence rate is 5.5 with a 95% confidence interval from 5.2 to 5.7 and 424 average annual cases over 2018-2022.
• CI*Rank ⋔ : 17 (7, 25)
• Percent of Cases with Late Stage :

Connecticut⁷

• Rate : The incidence rate is 4.4 with a 95% confidence interval from 4.2 to 4.7 and 212 average annual cases over 2018-2022.
• CI*Rank ⋔ : 43 (29, 48)
• Percent of Cases with Late Stage :

Nebraska²

• Rate : The incidence rate is 5.5 with a 95% confidence interval from 5.1 to 6.0 and 130 average annual cases over 2018-2022.
• CI*Rank ⋔ : 13 (4, 29)
• Percent of Cases with Late Stage :

Oklahoma²

• Rate : The incidence rate is 6.2 with a 95% confidence interval from 5.9 to 6.6 and 295 average annual cases over 2018-2022.
• CI*Rank ⋔ : 5 (1, 10)
• Percent of Cases with Late Stage :

Oregon²

• Rate : The incidence rate is 4.6 with a 95% confidence interval from 4.4 to 4.9 and 255 average annual cases over 2018-2022.
• CI*Rank ⋔ : 36 (25, 46)
• Percent of Cases with Late Stage :

Georgia⁷

• Rate : The incidence rate is 5.2 with a 95% confidence interval from 5.1 to 5.4 and 644 average annual cases over 2018-2022.
• CI*Rank ⋔ : 22 (13, 28)
• Percent of Cases with Late Stage :

North Dakota²

• Rate : The incidence rate is 5.6 with a 95% confidence interval from 5.0 to 6.4 and 51 average annual cases over 2018-2022.
• CI*Rank ⋔ : 9 (1, 38)
• Percent of Cases with Late Stage :

Pennsylvania²

• Rate : The incidence rate is 4.6 with a 95% confidence interval from 4.4 to 4.7 and 803 average annual cases over 2018-2022.
• CI*Rank ⋔ : 38 (29, 45)
• Percent of Cases with Late Stage :

Kansas²

• Rate : The incidence rate is 5.6 with a 95% confidence interval from 5.2 to 6.0 and 194 average annual cases over 2018-2022.
• CI*Rank ⋔ : 12 (5, 26)
• Percent of Cases with Late Stage :

Missouri²

• Rate : The incidence rate is 5.8 with a 95% confidence interval from 5.5 to 6.0 and 453 average annual cases over 2018-2022.
• CI*Rank ⋔ : 8 (5, 19)
• Percent of Cases with Late Stage :

Montana²

• Rate : The incidence rate is 4.8 with a 95% confidence interval from 4.3 to 5.3 and 70 average annual cases over 2018-2022.
• CI*Rank ⋔ : 31 (12, 48)
• Percent of Cases with Late Stage :

Alaska²

• Rate : The incidence rate is 5.2 with a 95% confidence interval from 4.4 to 6.0 and 41 average annual cases over 2018-2022.
• CI*Rank ⋔ : 23 (3, 47)
• Percent of Cases with Late Stage :

Arizona²

• Rate : The incidence rate is 4.6 with a 95% confidence interval from 4.4 to 4.8 and 422 average annual cases over 2018-2022.
• CI*Rank ⋔ : 37 (28, 46)
• Percent of Cases with Late Stage :

South Dakota²

• Rate : The incidence rate is 5.1 with a 95% confidence interval from 4.5 to 5.8 and 58 average annual cases over 2018-2022.
• CI*Rank ⋔ : 25 (6, 46)
• Percent of Cases with Late Stage :

Florida²

• Rate : The incidence rate is 4.5 with a 95% confidence interval from 4.4 to 4.6 and 1,403 average annual cases over 2018-2022.
• CI*Rank ⋔ : 42 (32, 46)
• Percent of Cases with Late Stage :

Louisiana⁷

• Rate : The incidence rate is 6.7 with a 95% confidence interval from 6.4 to 7.0 and 374 average annual cases over 2018-2022.
• CI*Rank ⋔ : 1 (1, 5)
• Percent of Cases with Late Stage :

New York⁷

• Rate : The incidence rate is 4.6 with a 95% confidence interval from 4.5 to 4.7 and 1,164 average annual cases over 2018-2022.
• CI*Rank ⋔ : 35 (29, 44)
• Percent of Cases with Late Stage :

Idaho⁷

• Rate : The incidence rate is 5.0 with a 95% confidence interval from 4.6 to 5.5 and 111 average annual cases over 2018-2022.
• CI*Rank ⋔ : 27 (10, 44)
• Percent of Cases with Late Stage :

South Carolina²

• Rate : The incidence rate is 4.9 with a 95% confidence interval from 4.7 to 5.2 and 333 average annual cases over 2018-2022.
• CI*Rank ⋔ : 29 (20, 39)
• Percent of Cases with Late Stage :

New Hampshire²

• Rate : The incidence rate is 4.6 with a 95% confidence interval from 4.1 to 5.0 and 89 average annual cases over 2018-2022.
• CI*Rank ⋔ : 41 (22, 49)
• Percent of Cases with Late Stage :

Utah⁷

• Rate : The incidence rate is 4.4 with a 95% confidence interval from 4.0 to 4.7 and 130 average annual cases over 2018-2022.
• CI*Rank ⋔ : 45 (28, 49)
• Percent of Cases with Late Stage :

Colorado²

• Rate : The incidence rate is 4.0 with a 95% confidence interval from 3.7 to 4.2 and 261 average annual cases over 2018-2022.
• CI*Rank ⋔ : 49 (44, 50)
• Percent of Cases with Late Stage :

Tennessee²

• Rate : The incidence rate is 5.3 with a 95% confidence interval from 5.1 to 5.5 and 457 average annual cases over 2018-2022.
• CI*Rank ⋔ : 20 (11, 28)
• Percent of Cases with Late Stage :

North Carolina²

• Rate : The incidence rate is 5.0 with a 95% confidence interval from 4.9 to 5.2 and 658 average annual cases over 2018-2022.
• CI*Rank ⋔ : 26 (19, 32)
• Percent of Cases with Late Stage :

Nevada²

• Rate : The incidence rate is 3.6 with a 95% confidence interval from 3.3 to 3.9 and 137 average annual cases over 2018-2022.
• CI*Rank ⋔ : 50 (48, 51)
• Percent of Cases with Late Stage :

Maryland²

• Rate : The incidence rate is 4.1 with a 95% confidence interval from 3.9 to 4.3 and 310 average annual cases over 2018-2022.
• CI*Rank ⋔ : 48 (43, 50)
• Percent of Cases with Late Stage :

Virginia²

• Rate : The incidence rate is 4.1 with a 95% confidence interval from 3.9 to 4.3 and 431 average annual cases over 2018-2022.
• CI*Rank ⋔ : 47 (43, 49)
• Percent of Cases with Late Stage :

Arkansas²

• Rate : The incidence rate is 5.5 with a 95% confidence interval from 5.1 to 5.8 and 207 average annual cases over 2018-2022.
• CI*Rank ⋔ : 15 (6, 28)
• Percent of Cases with Late Stage :

Alabama²

• Rate : The incidence rate is 4.6 with a 95% confidence interval from 4.3 to 4.8 and 294 average annual cases over 2018-2022.
• CI*Rank ⋔ : 39 (27, 46)
• Percent of Cases with Late Stage :

Mississippi²

• Rate : The incidence rate is 5.4 with a 95% confidence interval from 5.0 to 5.7 and 198 average annual cases over 2018-2022.
• CI*Rank ⋔ : 19 (7, 29)
• Percent of Cases with Late Stage :

Delaware²

• Rate : The incidence rate is 4.3 with a 95% confidence interval from 3.8 to 4.8 and 57 average annual cases over 2018-2022.
• CI*Rank ⋔ : 46 (24, 50)
• Percent of Cases with Late Stage :

District of Columbia²

• Rate : The incidence rate is 2.9 with a 95% confidence interval from 2.4 to 3.6 and 20 average annual cases over 2018-2022.
• CI*Rank ⋔ : 51 (50, 51)
• Percent of Cases with Late Stage :

Puerto Rico²

• Rate : The incidence rate is 2.0 with a 95% confidence interval from 1.9 to 2.2 and 100 average annual cases over 2018-2022.
• CI*Rank ⋔ : N/A
• Percent of Cases with Late Stage :

Notes:
Created by statecancerprofiles.cancer.gov on 03/29/2026 3:57 am.

State Cancer Registries may provide more current or more local data.

† Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (SEER areas use 20 age groups and NPCR areas use 19 age groups). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Rates calculated using SEER*Stat. Population counts for denominators are based on Census populations as modified by NCI. The US Population Data File is used for SEER and NPCR incidence rates.

Rates are computed using cancers classified as malignant based on ICD-O-3. For more information see malignant.html.

^ Late Stage is defined as cases determined to be regional or distant. Due to changes in stage coding, Combined Summary Stage with Expanded Regional Codes (2004+) is used for data from Surveillance, Epidemiology, and End Results (SEER) databases and Merged Summary Stage is used for data from National Program of Cancer Registries databases. Due to the increased complexity with staging, other staging variables maybe used if necessary.

Source: SEER and NPCR data. For more specific information please see the table.

Data for United States does not include Puerto Rico.